| Name | Title | Contact Details |
|---|
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
Twin Med is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
landmark is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MicroBioLogics is a Saint Cloud, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Claret Medical has been the leader in the field of cerebral protection since 2011, with approximately 97% market share in Europe, and is the first in the category to be commercially available in the U.S.